Table 2.
Mean scores and standard deviations for study variables at baseline, end of chemotherapys and 6-month follow-up tests for the intervention and control groups.
| Intervention group | Control group | |||||
|---|---|---|---|---|---|---|
| Baseline (n = 33) |
End of chemotherapy Post1 (n = 29) |
Followup Post2 (n = 25) |
Baseline (n = 34) |
End of chemotherapy Post1 (n = 31) |
Followup Post2 (n = 28) |
|
| Schwartz Cancer Fatigue Scale-6a | 10.28 (3.93) | 12.01 (4.38) | 10.43 (3.27) | 11.36 (3.56) | 13.13 (4.47) | 10.42 (3.21) |
| 6-Minute Walk Testb | 656.89 (63.30) | 644.02 (63.30) | 678.62 (73.27) | 638.64 (57.44) | 628.33 (60.44) | 643.39 (54.00) |
| MET-minutes/weekc | 1333.66 (1367.67) | 1621.12 (1734.42) | 2105.63 (2104.75) | 1138.00 (1148.81) | 1018.97 (1396.25) | 1844.94 (1555.35) |
aFatigue scores ranging from 6 to 30.
bReported in meters.
cSelf-reported physical activity level (International Physical Activity Questionnaire short form) measured in metabolic equivalent of task (MET) minutes.